PORTAGE, MICHIGAN (AP) — United States (US) President Joe Biden toured a state-of-the art coronavirus vaccine plant on Friday, intent on showcasing progress even as extreme winter weather across the US handed his vaccination campaign its first major setback, delaying shipment of about six million doses and causing temporary closures of inoculation sites in many communities.
While acknowledging the weather is “slowing up the distribution”, Biden said at the Pfizer plant in Michigan that he believes “we’ll be approaching normalcy by the end of this year”.
His speech melded a recitation of his administration’s accomplishments in its first month confronting the pandemic, a vigorous pitch for his USD1.9 trillion COVID relief bill and criticism of his predecessor.
The disruptions caused by frigid temperatures, snow and ice have left the White House and states scrambling to make up lost ground as three days’ worth of vaccine shipments were temporarily delayed. Even the president’s trip to see Pfizer’s largest plant was pushed back a day due to a storm affecting the nation’s capital.
Before the trip, White House coronavirus response adviser Andy Slavitt said the federal government, states and local vaccinators are going to have to redouble efforts to catch up after the interruptions.
The setback comes just as the vaccination campaign seemed to be on the verge of hitting its stride.
All the backlogged doses should be delivered in the next several days, Slavitt said, still confident that the pace of vaccinations will recover.
Biden has set a goal of administering 100 million shots in his administration’s first 100 days, and he said on Friday that’s still on track and it’s only a beginning.
He said that by the end of July his administration can deliver 600 million doses for Americans.
Still, Biden cautioned that timetable could change, citing the current weather delays and concerns about new strains of the virus as well as the possibility that production rates could fluctuate.
The Pfizer plant Biden toured, near Kalamazoo, produces one of the two federally approved COVID-19 shots. Weather-related delays have affected distribution of both the Pfizer and Moderna vaccines.